TWAV headed into its earnings print this week carrying a 22% loss over the past five days — a bruising setup for a micro-cap software name already trading at $1.46.
The results themselves were a genuine positive surprise. Q1 EPS came in at $0.43, a sharp reversal from a loss of $0.59 in the same quarter a year ago, while revenue rose to $707K from $622K year-on-year. The 10-Q landed on May 15. Despite that, the stock fell a further 3.9% on Friday. The market's verdict: the beat was either already priced in, or too small to matter against a broader backdrop of selling pressure.
The short-selling picture is part of what makes this week's price action unusual. Short interest has been actively unwinding, not building. It dropped 34% over the week to just under 2% of the free float — half the level seen at the start of May, when shorts held roughly 4% of the float. Over the past month, estimated short interest has fallen more than 51%. Borrow costs have followed the same trajectory, easing from above 14% in early April to 6.3% now. Availability is extremely loose at 839%, meaning there are roughly eight shares available to borrow for every one currently lent out. There is no meaningful short squeeze pressure here. The selling this week has been driven by long-side exits, not shorts.
The ORTEX short score has also broken sharply lower, dropping from near 56 at the start of May to 37.7 by May 14 — a significant de-escalation in the bearish signals the model had been flagging through April. That move aligns with the availability and cost-to-borrow data: the borrow market has gone from moderately stressed to almost entirely relaxed inside six weeks. The 52-week peak utilization of 98.6% now feels like a distant episode.
Earnings history provides some context for the volatility. The last four events have produced day-one moves ranging from a 26% drop to an 11.5% gain. The five-day aftermath has been similarly wide: the November 2025 print led to a 34% five-day loss, while March 2026 saw a 17% five-day gain. The Q1 2026 result, reported May 15 with an upcoming follow-on event flagged for May 20, has so far delivered neither the relief rally nor the post-earnings flush that recent history might suggest. That May 20 date is the next concrete catalyst worth watching.
Institutional ownership is thin — only 13 holders on record, with Jon Hall at 7% of shares and Citadel and Renaissance each holding around 2%. The insider register shows a pattern of modest open-market buying by the CEO Peter Holst and Chairman Jonathan Schechter in the September–November 2025 period, at prices between $1.84 and $2.73 — all well above where the stock trades today. Those purchases are now six months stale and underwater, which limits their signalling power as a near-term support indicator. The peer group, which correlates most closely with crypto-adjacent names like MARA, BTBT, and CLSK, all fell sharply on the day, suggesting broader risk-off sentiment in speculative small-caps amplified TWAV's decline.
Overall, the positioning story has flipped from cautious to neutral: shorts have largely left the building, borrow conditions are relaxed, and the short score has collapsed — but the price keeps falling, leaving the May 20 event as the next moment where the market will be forced to take a fresh view.
See the live data behind this article on ORTEX.
Open TWAV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
